Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04854018
What this trial is testing

Indo-cyanine Green (ICG) in Paediatric Oncology MIS

Who this might be right for
Pediatric Renal TumorMetastatic OsteosarcomaMetastatic Ewing Sarcoma+3 more
Birmingham Women's and Children's NHS Foundation Trust 20
Early research (Phase 1)Study completedNCT00581815
What this trial is testing

Spectroscopy With Surface Coils and Decoupling

Who this might be right for
Adrenal Cortical CancerBrain CancerBreast Cancer+16 more
Memorial Sloan Kettering Cancer Center 582
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Testing effectiveness (Phase 2)UnknownNCT04029350
What this trial is testing

Study of Anlotinib Combined With Osimertinib as Second-line Treatment in Stage IIIb-IV NSCLC With Confirmed EGFRm and T790M

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 53
Very early researchEnrolling By InvitationNCT06747832
What this trial is testing

INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Guangzhou Ruixin Biotechnological Co., LTD 10
Large-scale testing (Phase 3)UnknownNCT04254471
What this trial is testing

This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Haihe Biopharma Co., Ltd. 313
Not applicableStudy completedNCT04704349
What this trial is testing

Latest Imaging SPECT System Evaluation Phase 1

Who this might be right for
Rheumatic DiseaseNeoplasmsParathyroid Diseases+6 more
Centre Hospitalier Régional d'Orléans 68
Testing effectiveness (Phase 2)UnknownNCT05498389
What this trial is testing

EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaAdvanced Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8+6 more
Shanghai EpimAb Biotherapeutics Co., Ltd. 115
Not applicableWithdrawnNCT03519958
What this trial is testing

Epidermal Growth Factor Receptor (EGFR) T790M Mutation Testing Practices in Hong Kong

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca
Not applicableEnded earlyNCT05315908
What this trial is testing

COVID-19 Testing in Underserved and Vulnerable Populations

Who this might be right for
Heart FailureCoronary Artery DiseaseCancer+5 more
Jesse Nodora 9,120
Not applicableNot Yet RecruitingNCT07599943
What this trial is testing

Population Health Management -Increase Lung Cancer Screening in Community Health Centers (LungSMART)

Who this might be right for
Lung Cancer
University of Utah 18,894
Testing effectiveness (Phase 2)Active Not RecruitingNCT04922658
What this trial is testing

Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 76
Not applicableStudy completedNCT01069835
What this trial is testing

Epidemiological Study to Describe Non Small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Central Eastern Europe and Russia (Lung-EPICLIN)

Who this might be right for
Non Small Cell Lung Cancer
AstraZeneca 840
Testing effectiveness (Phase 2)Study completedNCT02250326
What this trial is testing

Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Celgene 240
Not applicableStudy completedNCT03537378
What this trial is testing

Hybrid APC Therapy in Early Central Lung Neoplasms

Who this might be right for
Lung Neoplasms
Jiayuan Sun 15
Not applicableStudy completedNCT06199050
What this trial is testing

The Effect of 360° Virtual Reality Movies on Fear and Anxiety

Who this might be right for
FearAnxietyBreast Cancer+4 more
Maastricht Radiation Oncology 292
Early research (Phase 1)Study completedNCT02228369
What this trial is testing

Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung Cancer

Who this might be right for
EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
AstraZeneca 108
Not applicableUnknownNCT03357094
What this trial is testing

Pulmonary Ventilation/Perfusion Imaging for the Prediction of Postoperative Residual Pulmonary Function

Who this might be right for
Lung Neoplasms
Beijing Tongren Hospital 50
Testing effectiveness (Phase 2)Study completedNCT03565003
What this trial is testing

A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China

Who this might be right for
Non-small Cell Lung CancerHead and Neck CancerEsophageal Cancer+1 more
Jacobio Pharmaceuticals Co., Ltd. 126
Testing effectiveness (Phase 2)Study completedNCT06289023
What this trial is testing

HA-WBRT-SIB for Brain Metastasis of Lung Cancer

Who this might be right for
Lung NeoplasmBrain MetastasesSimultaneous Integrated Boost+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Next Page